Fig. 1From: Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CTPlanar anterior and posterior whole-body 111In-pentetreotide imaging acquired at 4Â h and 24Â h demonstrating no pentetreotide-avid diseaseBack to article page